JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY |
(Exact name of registrant as specified in its charter) |
Ireland | 001-33500 | 98-1032470 | ||
(State or other jurisdiction of incorporation) | (Commission File No.) | (IRS Employer Identification No.) |
Fourth Floor, Connaught House, 1 Burlington Road, Dublin 4, Ireland |
(Address of principal executive offices, including zip code) |
(Registrant’s telephone number, including area code) |
Item 2.01. | Completion of Acquisition or Disposition of Assets. |
Item 9.01. | Financial Statements and Exhibits. |
(b) | Pro Forma Financial Information |
(d) | Exhibits |
Exhibit Number | Description | |
2.1 | Amended and Restated Agreement for the Acquisition of the Topaz Portfolio Business of Jazz Pharmaceuticals plc, dated March 20, 2015, between Jazz Pharmaceuticals plc and Essex Bidco Limited.* | |
99.1 | Unaudited pro forma condensed consolidated financial information for the year ended December 31, 2014 and the notes related thereto. |
* | Schedules and similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Jazz Pharmaceuticals plc undertakes to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request. |
JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY | ||
By: | /s/ Matthew P. Young | |
Name: | Matthew P. Young | |
Title: | Executive Vice President and Chief Financial Officer |
Exhibit Number | Description | |
2.1 | Amended and Restated Agreement for the Acquisition of the Topaz Portfolio Business of Jazz Pharmaceuticals plc, dated March 20, 2015, between Jazz Pharmaceuticals plc and Essex Bidco Limited.* | |
99.1 | Unaudited pro forma condensed consolidated financial information for the year ended December 31, 2014 and the notes related thereto. |
* | Schedules and similar attachments have been omitted pursuant to Item 601(b)(2) of Regulation S-K. Jazz Pharmaceuticals plc undertakes to furnish supplementally a copy of any omitted schedule to the Securities and Exchange Commission upon request. |
DATED | 20 MARCH 2015 | |
Jazz Pharmaceuticals PLC | ||
- and - | ||
Essex Bidco Limited | ||
AMENDED AND RESTATED AGREEMENT FOR THE ACQUISITION OF THE TOPAZ PORTFOLIO BUSINESS OF JAZZ PHARMACEUTICALS PLC |
T0825/00114 Ref: C1/TWB/JSR | ||
Hogan Lovells International LLP Atlantic House, Holborn Viaduct, London EC1A 2FG |
1. | INTERPRETATION 1 |
2. | SALE AND PURCHASE OF THE BUSINESS AND ASSETS 15 |
3. | PURCHASE PRICE 16 |
4. | VAT AND OTHER TAX ISSUES 20 |
5. | COMPLETION 24 |
6. | BUYER'S WARRANTIES 27 |
7. | SELLER'S WARRANTIES 27 |
8. | LIMITATIONS ON SELLER'S LIABILITY 28 |
9. | BUSINESS RESPONSIBILITY 28 |
10. | TRANSFER OF CONTRACTS 30 |
11. | WRONG POCKETS 31 |
12. | APPORTIONMENT OF OUTGOINGS AND INCOME 32 |
13. | COLLECTION OF ACCOUNTS RECEIVABLE FROM THE SALE OF INVENTORY TO CUSTOMERS 36 |
14. | EMPLOYEES 36 |
15. | RETIREMENT BENEFIT PLANS 41 |
16. | ACCESS TO INFORMATION AND EMPLOYEES AND USE OF NAMES 41 |
17. | DATA PROTECTION 43 |
18. | CONFIDENTIALITY 43 |
19. | ANNOUNCEMENTS 45 |
20. | COVENANTS 45 |
21. | ASSIGNMENT 46 |
22. | NOTICES AND CLAIMS FOR PAYMENT 47 |
23. | PAYMENTS 49 |
24. | FURTHER ASSURANCE 50 |
25. | COSTS 50 |
26. | GROSS UP 51 |
27. | INTEREST ON LATE PAYMENT 51 |
28. | VARIATION AND AMENDMENTS 51 |
29. | WAIVER 51 |
30. | COUNTERPARTS 52 |
31. | EFFECT OF COMPLETION 52 |
32. | ENTIRE AGREEMENT AND LOCAL AGREEMENTS 52 |
33. | INVALIDITY 52 |
34. | THIRD PARTY RIGHTS 53 |
35. | GOVERNING LAW AND ARBITRATION 54 |
1. |
2. |
3. |
4. |
5. |
6. |
7. | COVENANTS 75 |
8. |
9. |
10. | CONTRACTS 79 |
11. |
12. |
13. |
14. |
15. |
16. |
17. | WDA SCHEDULE 114 |
18. | FDA SCHEDULE 119 |
(1) | Jazz Pharmaceuticals PLC, a company incorporated in Ireland (registered number 399192) whose registered office is at Fourth Floor, Connaught House, One Burlington Road, Dublin 4, Ireland (the "Seller"); and |
(2) | Essex Bidco Limited, a company incorporated in England and Wales registered number 9329429), whose registered office is at Berkeley House, Berkeley Square, London, United Kingdom, W1J 6BR (the "Buyer"). |
(A) | The Seller and the Buyer entered in an agreement to sell and transfer, or procure the sale and transfer of, the Assets and the Business to the Buyer, and to purchase the Assets and the Business, on 30 December 2014. |
(B) | The Seller and the Buyer now wish to amend and restate that agreement on and subject to the terms of this Agreement. |
1. | INTERPRETATION |
1.1 | In this Agreement: |
(a) | where such balances are denominated in non-USD currencies, these shall be retranslated into USD at the Conversion Rate; |
(b) | a provision for the full amount shall be made against all receivables: |
(i) | in respect of Customers who are Partners, which have exceeded credit terms by more than eighteen (18) calendar months at the Effective Time; and |
(ii) | in respect of Customers who are Direct Customers, which have exceeded credit terms by more than nine (9) calendar months at the Effective Time; and |
(c) | a specific provision shall be made against any receivable where the Customer has indicated to the Seller prior to the Effective Time that they are unable or unwilling to settle the invoiced sum either in full or in part; |
(a) | the Assumed Obligations; and |
(b) | except as otherwise provided in clauses 12 and 14, all obligations and other liabilities of the Seller or any Seller's Group Company relating to the ownership of an Asset or the operation of the Business by the Buyer or any relevant Buyer's Group Company after the Effective Time, including any obligations and other liabilities arising in connection with the research, development, testing, manufacture, handling, labelling, packaging, storage, open product purchase orders, supply, promotion, employee related costs, distribution, marketing, import, export and sale of the Topaz Portfolio of Products and the ATU Business and the processing of the Transferred Data after the Effective Time; |
(a) | the trade marks and domain names listed in Schedule 14; and |
(b) | such Intellectual Property as is comprised within or used in relation to the Topaz Portfolio of Products and the ATU Products, including the Business Marketing Materials, where such Intellectual Property is owned by a Seller's Group Company and used solely or primarily for the purposes of the Business; |
(a) | all labelling, packaging or package inserts used by the Business in relation to the Topaz Portfolio of Products and the ATU Products; and |
(b) | informational letters, sales training materials, trade show materials (including materials containing post-marketing clinical data, if any), advertising, marketing, sales and promotional materials used by the Business in relation to the Topaz Portfolio of Products and the ATU Products, |
(a) | is publicly known at the Signing Date or which subsequently becomes publicly known (other than in either case as a result of a breach of the provisions of the Confidentiality Agreement or a Transaction Document by a Seller's Group Company). A compilation of otherwise public information in a form not publicly known is to be regarded as not publicly known; |
(b) | the Seller can show was made known to it after Signing by a person unconnected with a Buyer's Group Company who was entitled to do so (and not in breach of an obligation of confidence) and who did not impose an obligation of confidence or restricted use; or |
(c) | the Seller or any Seller's Group Company has retained or acquired rights in under a Transaction Document; |
(a) | patents, utility models, rights in inventions, registered and unregistered trade and service marks, rights in business and trade names and get-up, rights in domain names, registered designs, unregistered rights in designs, copyrights and neighbouring rights, rights in performances, database rights, rights in know-how and, in each case, rights of a similar or corresponding character in each case for their full term including any extensions and renewals; and |
(b) | all applications and rights to apply for the protection of any of the rights referred to in paragraph (a) above; |
(a) | the value of such inventory shall be calculated by taking the lower of cost or market value; |
(b) | cost shall be expressed as the original invoice cost of the inventory and any directly attributable cost incurred in transporting the inventory to its warehouse location; |
(c) | no value shall be attributed to any inventory where the age is within twelve (12) months of expiry (as shown on the package) in respect of Caphosol finished goods and within six (6) months of expiry (as shown on the package) in respect of finished goods for other products comprised within the Business; and |
(d) | where inventory value is denominated in non-USD currencies, this shall be retranslated into USD at the Conversion Rate; |
(a) | Collatamp – the world other than the United States of America and its possessions and territories; |
(b) | Caphosol – the world; |
(c) | Xenazine – France (including French overseas departments), Belgium, Luxembourg, Morocco, Algeria and Lebanon; |
(d) | Custodiol – France and Portugal; and |
(e) | Fomepizole – EU (except France), Switzerland, Iceland, Norway, the former Yugoslav Republic of Macedonia, Serbia, Bosnia and Herzegovina, Montenegro, Kosovo, Turkey, Korea, Taiwan, China, Hong Kong, Singapore, Malaysia, India, Pakistan, Thailand, Philippines, Indonesia and Japan; |
(a) | any relief, allowance, credit, deduction, exemption or set off in respect of any Tax or relevant to the computation of any income, profits or gains; or |
(b) | any right to repayment of or savings of Tax, |
(a) | the Retained Obligations; and |
(b) | except as otherwise provided in clauses 12 and 14, all obligations and other liabilities of the Seller or any Seller's Group Company relating to the ownership of an Asset or the operation of the Business by the Seller or any relevant Seller’s Group Company in the period up to and including the Effective Time, including any obligations and other liabilities arising in connection with the research, development, testing, manufacture, handling, labelling, packaging, storage, supply, promotion, distribution, marketing, import, export and sale of the Topaz Portfolio of Products and the ATU Business and the processing of the Transferred Data in the period up to and including the Effective Time; |
(a) | is publicly known at Completion or which subsequently becomes publicly known (other than in either case as a result of a breach of the provisions of the Confidentiality Agreement or a Transaction Document by a Buyer's Group Company). A compilation of otherwise public information in a form not publicly known is to be regarded as not publicly known; |
(b) | the Buyer can show was made known to it after Signing by a person unconnected with the Seller's Group who was entitled to do so (and not in breach of an obligation of confidence) and who did not impose an obligation of confidence or restricted use; or |
(c) | the Buyer has retained or acquired rights in under a Transaction Document; |
(a) | relates to or is entered into in connection with the sale by the Seller and the purchase by the Buyer of the Business and the Assets; and |
(b) | is contemplated in a Transaction Document; |
(a) | this Agreement; |
(b) | the Disclosure Letter; |
(c) | the Transitional Services Agreement; |
(d) | the Reverse Services Agreement; |
(e) | the Domain Name Assignment Agreement; |
(f) | the Trade Mark Assignment Agreement; and |
(g) | each document that the Seller or the Buyer is to enter into after the Signing Date under the terms of an agreement or document referred to in paragraphs (a) to (f); |
1.2 | In this Agreement: |
(a) | a reference to a clause, paragraph or schedule is, unless stated otherwise, a reference to a clause or paragraph of, or schedule to, this Agreement; |
(b) | a reference in a schedule to a paragraph is, unless otherwise stated, a reference to a paragraph in that schedule or, where that schedule is split into parts, a reference to a paragraph in that part of that schedule; |
(c) | a reference to any statute or statutory provision is a reference to that statute or statutory provision as re-enacted, re-numbered, amended or extended before the Offer Date and includes reference to any subordinate legislation (as re-enacted, amended or extended) made under it before the Offer Date; |
(d) | a reference to a "person" includes any individual, company, corporation, firm, partnership, joint venture, association, state, state agency, institution or trust (whether or not having a separate legal personality); |
(e) | a reference to a document being in the "agreed form" is a reference to a document in the form and terms approved and, for the purposes of identification only, initialled, by or on behalf of each party on or before the Offer Date with any alterations that are agreed in writing by or on behalf of each party at any time before Completion; |
(f) | a reference to one gender is a reference to all or any genders; |
(g) | a reference to a particular time of day is, unless stated otherwise, a reference to that time in London, England; |
(h) | a reference to a person's "Group" is, unless otherwise stated, a reference to that person, its subsidiary undertakings, its parent undertakings and any other subsidiary undertakings of its parent undertakings; |
(i) | a reference to "including" or "includes" does not limit the scope of the meaning of the words preceding it; |
(j) | the expressions "subsidiary undertaking" and "parent undertaking" have the meanings given to them by the Companies Act 2006; |
(k) | the expression "connected" with reference to a person or group of persons has the meaning given to it in sections 1122 and 1123 of the Corporation Tax Act 2010; and |
(l) | the definitions contained in this Agreement are applicable to the singular as well as the plural forms of such terms |
1.3 | In this Agreement, a reference in relation to any Intellectual Property, to "use" includes any act which would constitute an infringement if done without the permission of the owner of the Intellectual Property. |
1.4 | The Schedules form part of this Agreement and a reference to "this Agreement" includes its Schedules. |
1.5 | The headings in this Agreement do not affect its interpretation. |
2. | SALE AND PURCHASE OF THE BUSINESS AND ASSETS |
2.1 | Agreement to sell and buy |
(a) | the Seller agrees to sell, or procure that the relevant Seller's Group Company sells; and |
(b) | the Buyer agrees to buy (or procure that the relevant Buyer’s Group Company buys) (and assume (or procure that the relevant Buyer’s Group Company assumes) in the case of the Assumed Liabilities), |
(c) | the Business, including the Assets free from all Encumbrances other than, in the case of the Inventory only, any title transfer or retention of title provision relating to the purchase of that Inventory that is usual in the normal course of the Business; and |
(d) | the Assumed Liabilities, |
(e) | the Retained Assets; or |
(f) | the Retained Liabilities. |
2.2 | The Assets |
(a) | subject to clause 10, the benefit of the Contracts and the benefit of the Shared Contracts in so far as that benefit applies to the Business; |
(b) | the Goodwill; |
(c) | the Marketing Authorisations; |
(d) | the Business Intellectual Property; |
(e) | the Business Marketing Materials; |
(f) | the Equipment; |
(g) | the Transferred Names and UPCs; |
(h) | the Business Information; and |
(i) | the Inventory and Accounts Receivable from the Sale of Inventory to Customers. |
2.3 | The Retained Assets |
(a) | (excluding the benefit of the Shared Contracts in so far as that benefit applies to the Business) the Retained Contracts; |
(b) | the Retained Information; and |
(c) | the Seller Group's cash and each amount credited to an account with a financial institution for the benefit of the Seller Group. |
2.4 | Nomination of Buyer's Group Companies |
3. | PURCHASE PRICE |
3.1 | Amount |
(a) | clause 3.4 (a), at Completion; |
(b) | clause 3.4(b), following Completion; |
(c) | clause 3.5, at Completion; and |
(d) | clause 3.6, following Completion. |
3.2 | Allocation of Purchase Price |
3.3 | Payment method |
3.4 | Purchase Price adjustment |
(a) | Purchase Price at Completion |
(i) | Calculation of Purchase Price |
(1) | If the aggregate of (i) the Estimated Inventory Value and (ii) the Estimated Accounts Receivable from the Sale of Inventory to Customers Value is lower than the Target Transferred Asset Value, the Purchase Price shall be reduced by the difference between such aggregate and the Target Transferred Asset Value. |
(2) | If the aggregate of (i) the Estimated Inventory Value and (ii) the Estimated Accounts Receivable from the Sale of Inventory to Customers Value is higher than the Target Transferred Asset Value, the Purchase Price shall be increased by the difference between such aggregate and the Target Transferred Asset Value. |
(ii) | Procedure |
(1) | No less than fifteen (15) days before the Completion Date, the Seller shall furnish the Buyer with a statement that shows the Estimated Inventory Value and the Estimated Accounts Receivable from the Sale of Inventory to Customers Value based on the calculations and balance sheet positions for the month end immediately preceding the Completion Date or, in the event that the Completion Date falls on or before the fifteenth (15) day of the month, the prior month end (the "Estimated Completion Statement"). |
(2) | The parties shall co-operate in facilitating the computation and review of the Estimated Completion Statement and the Seller shall procure such access for the Buyer and its representatives to the Seller's and each Seller's Group Company's books, records and employees as the Buyer may reasonably request for such task. The Buyer may, within ten (10) Business Days of receipt of the Estimated Completion Statement, request any reasonable amendments to the Estimated Completion Statement and the Seller shall use its reasonable endeavours to agree such changes. Subject to any such changes which the Seller may agree, the Seller's determination of the Estimated Completion Statement shall be final and binding on the parties. |
(b) | Post-Completion adjustment |
(i) | After the Completion Date the Seller shall commence preparation of a statement that shows the Inventory Value, the Accounts Receivable from the Sale of Inventory to Customers Value and the French Employee Retirement Fund Liability (the "Proposed Final Completion Statement"). |
(ii) | The parties shall cooperate with each other in facilitating the computation and review of the Proposed Final Completion Statement and, after the Completion Date, each party shall furnish such access for the other party and its representatives to each Seller's Group Company's or Buyer's Group Company's (as the case may be) books, records and employees as that party may reasonably request for such task. |
(iii) | Within forty (40) days after the Completion Date, the Seller shall furnish the Proposed Final Completion Statement to the Buyer with a notice explaining in reasonable detail the computation of the Inventory Value, the Accounts Receivable from the Sale of Inventory to Customers Value and the French Employee Retirement Fund Liability including but not limited to details of all accounting or actuarial policies used to calculate the French Employee Retirement Fund Liability (if any required by law, regulation or reasonable accounting and actuarial policies and principles). The computations set forth in the Proposed Final Completion Statement shall become final and binding upon the parties unless the Buyer gives written notice (the "Dispute Notice") to the Seller within forty-five (45) days following receipt of the Proposed Final |
(c) | Resolution of disputes |
(i) | The Seller and the Buyer shall attempt to promptly resolve in good faith any Disputed Items. Any written resolution by the Seller and the Buyer as to such Disputed Items shall be final and binding on the parties. |
(ii) | If the Seller and the Buyer do not reach a resolution of all Disputed Items within thirty (30) Business Days after delivery of the relevant Dispute Notice, then the Seller and the Buyer shall promptly enter into a customary engagement agreement with the Neutral Accountant and submit such unresolved Disputed Items to the Neutral Accountant for final resolution. |
(iii) | The Neutral Accountant shall act as an expert, not as an arbitrator, in resolving such Disputed Items. The proceeding before the Neutral Accountant shall be an expert determination under applicable laws governing expert determination and appraisal proceedings. All communications between the Seller and the Buyer or any of their respective representatives, on the one hand, and the Neutral Accountant, on the other hand, shall be in writing with copies simultaneously delivered to the non-communicating party. |
(iv) | The Neutral Accountant shall be instructed promptly, in accordance with the rules set forth in the Neutral Accountant’s engagement letter and its customary practices, to review only those unresolved Disputed Items specifically set forth and objected to in the Dispute Notice and resolve the dispute with respect to each such specific Disputed Item. A single partner of the Neutral Accountant selected by such Neutral Accountant in accordance with its normal procedures and having expertise with respect to settlement of such disputes and the industry in which the Business operates shall act for the Neutral Accountant in the determination proceeding, and the Neutral Accountant shall render a written decision as to each Disputed Item, including a statement in reasonable detail of the basis for its decision. In no event shall the decision of the Neutral Accountant provide for a calculation of any element of the Purchase Price that is less than the lower calculation thereof shown in the Proposed Final Completion Statement or in the Dispute Notice or greater than the higher calculation thereof shown in the Proposed Final Completion Statement or in the Dispute Notice. |
(v) | The Neutral Accountant shall be instructed to resolve the unresolved Disputed Items in accordance with the definitions of Inventory Value or (as appropriate) the Accounts Receivable from the Sale of Inventory to Customers Value and shall be instructed not to investigate any other matters. The Seller and the Buyer shall request that the Neutral Accountant make a final determination (which determination shall set forth the reasons for such determination) of the Inventory Value and the Accounts Receivable from the Sale of Inventory to Customers Value, within thirty (30) days from the date |
(vi) | The final determination by the Neutral Accountant of the Disputed Items submitted to it for resolution shall be conclusive and binding upon the parties, except in the case of fraud or manifest error. The parties agree that the procedure set forth in this clause 3.4(c) for resolving disputes with respect to the Proposed Final Completion Statement shall be the sole and exclusive method for resolving any such disputes. The fees and expenses of the Neutral Accountant shall be shared equally between the Seller on the one hand and the Buyer on the other hand, unless the Neutral Accountant determines otherwise due to the conduct of one party or the other. |
(vii) | The Proposed Final Completion Statement, including any modifications resulting from the resolution of any Disputed Items set forth in any Dispute Notice, shall be deemed to be the Final Completion Statement and be binding on the parties for the purposes of this clause 3.4 upon (i) the failure of the Seller to submit a timely Dispute Notice pursuant to clause 3.4(b), (ii) the resolution of all Disputed Items by the Seller and the Buyer pursuant to clause 3.4(c)(i), or (iii) the resolution of any otherwise unresolved Disputed Items pursuant to clause 3.4(c)(v) by the Neutral Accountant. |
(d) | Settlement |
(i) | If the aggregate of the Accounts Receivable from the Sale of Inventory to Customers Value and the Inventory Value components of the Purchase Price, as calculated based on the Final Completion Statement, exceeds the aggregate of the Estimated Accounts Receivable from the Sale of Inventory to Customers Value and the Estimated Inventory Value, the Buyer shall pay to the Seller an amount equal to such excess. |
(ii) | If the aggregate of the Accounts Receivable from the Sale of Inventory to Customers Value and the Inventory Value components of the Purchase Price, as calculated based on the Final Completion Statement, is less than the aggregate of the Estimated Accounts Receivable from the Sale of Inventory to Customers Value and the Estimated Inventory Value, the Seller shall pay to the Buyer an amount equal to such deficiency. |
(iii) | The Seller shall make a payment to the Buyer in an amount equal to the French Employee Retirement Fund Liability. |
3.5 | 2014 Bonus Accrual Amount |
3.6 | Amounts paid by Seller, Relevant Seller's Group Company, Buyer or Nominated Buyer Company deemed an adjustment to the Purchase Price |
(a) | A payment made by the Seller, or a Relevant Seller's Group Company, to the Buyer or a Nominated Buyer Company (as applicable) under an indemnity contained in this Agreement, in respect of a Claim, or under clause 14, or by the Buyer, or a Nominated Buyer Company, to the Seller or a Relevant Seller's Group Company (as applicable) under this Agreement, will be treated as having reduced or increased the Purchase Price (as appropriate) by the amount of the payment but will not reduce the Purchase Price to below zero. This clause does not limit the amount that the Buyer may claim under this Agreement. |
(b) | Any adjustment under clause 3.6(a) will be allocated as nearly as possible to the class of Asset to which it relates, and if in respect of more than one class of Asset, in the proportion to which the original allocation of the Purchase Price was made. |
4. | VAT AND OTHER TAX ISSUES |
4.1 | Payments exclusive of VAT |
4.2 | Transfer of a going concern |
(a) | the VAT legislation of the respective countries in which the Assets are treated as supplied for VAT purposes (or would be so treated if the relevant transaction were not a TOGC (as defined below)): |
(i) | by the Seller or any Relevant Seller's Group Company or, if applicable, any representative member of any VAT group of which the Seller or any Relevant Seller's Group Company is a member (a "Seller Representative Member"); and |
(ii) | to the Buyer or any Nominated Buyer Company or, if applicable, any representative member of any VAT group of which the Buyer or any Nominated Buyer Company is a member (a "Buyer Representative Member"), |
(b) | the conditions for a TOGC are met in respect of any transfer of the Business and Assets (or any part of them) by the Seller or any Relevant Seller's Group Company |
4.3 | Seller warranties |
(a) | it is (and the Relevant Seller’s Group Companies or, if applicable, any Seller Representative Members are) duly registered for VAT purposes in any relevant jurisdiction; and |
(b) | to the extent that the transfer of the Business and Assets in any relevant jurisdiction is intended by the parties to be treated as a TOGC for VAT purposes as referred to in clause 4.2, the Business (together with the Assets) is operated as a going concern in such jurisdiction. |
4.4 | Buyer's warranties |
(a) | from and including the Effective Time, it or the relevant Nominated Buyer Company (or, if applicable, the relevant Buyer Representative Member) is duly registered for the purposes of VAT in any relevant jurisdiction or will as a result of the transfer of the Business and Assets from the Seller or the Relevant Seller’s Group Company to the Buyer (or the relevant Nominated Buyer Company) be immediately required to be so registered (if such registration or requirement to be so registered is a requirement of TOGC treatment under the VAT law in the relevant jurisdiction); |
(b) | it or the Relevant Nominated Buyer Company is not buying the Business and Assets as nominee or agent for another party; |
(c) | following Completion, it intends to use (or to procure that any relevant Nominated Buyer Company uses) the Business and the Assets to carry on the same kind of business as that carried on by the Seller and the Relevant Seller's Group Companies prior to Completion; and |
(d) | there will be no significant break in the normal trading pattern of the Business immediately after Completion. |
4.5 | VAT records |
4.6 | Action if VAT is payable |
(a) | as soon as practicable after the Seller, the Relevant Seller's Group Company or the relevant Seller Representative Member (as applicable) receives such determination, the Seller shall deliver a copy of it to the Buyer, together with a valid VAT invoice for the amount of VAT specified in the determination (issued by the Seller or the Relevant Seller's Group Company (as applicable)); and |
(b) | the Buyer will (or will procure that the relevant Nominated Buyer Company will) pay the Seller (or the Relevant Seller's Group Company) the amount of VAT stated in the invoice within five (5) Business Days after receipt of the invoice and, in addition, shall within the said five (5) Business Days pay any interest or penalty for which the Seller, the Relevant Seller's Group Company or the relevant Seller Representative Member (as applicable) is liable in relation to such VAT, but only to the extent that any such liability to interest or penalty arises by reason other than any default by the Seller, the Relevant Seller's Group Company or the relevant Seller Representative Member (as applicable). |
4.7 | Reimbursement by Seller of amounts paid under clause 4 |
(a) | shall (or shall procure that the Relevant Seller's Group Company or the relevant Seller Representative Member (as applicable) shall) apply to the relevant Tax Authority for a refund of the VAT (plus any interest payable as applicable under the applicable VAT legislation) and shall take all reasonable steps (at the reasonable cost of the Buyer) to procure that any such refund and interest are obtained promptly; and |
(b) | shall (or shall procure that the Relevant Seller’s Group Company shall) pay to the Buyer (or the relevant Nominated Buyer Company) the amount of the refund and any interest when and to the extent received by the Seller, the Relevant Seller's Group Company or the relevant Seller Representative Member (as applicable) from the relevant Tax Authority. |
4.8 | US tax |
4.9 | French tax |
(a) | 3 per cent. for such portion of the French Purchase Price between EUR 23,000 and EUR 200,000 (or the market value, if higher); and |
(b) | 5 per cent. for such portion of the French Purchase Price exceeding EUR 200,000 (or the market value, if higher). |
5. | COMPLETION |
5.1 | Efforts |
5.2 | Pre-Completion |
5.3 | Buyer conditions to Completion |
(a) | the Fundamental Warranties shall be true and accurate in all respects as though such warranties had been made on the Completion Date; |
(b) | the Business Warranties shall be true and accurate as though such warranties had been made on the Completion Date (without giving effect to any "material", "materially", "materiality", "Material Adverse Effect", "material adverse effect", "material adverse change" or similar qualifiers contained in any of such warranties or contained in any defined term used in any of such warranties and except to the extent such warranties are, by their terms, made as of a specific date, in which case such warranties shall be true and correct in the foregoing manner as of such date), except for such failures to be true and accurate as would not have, individually or in the aggregate, a Material Adverse Effect; |
(c) | there shall not have occurred between the Offer Date and the Completion Date a material breach of the covenants referred to in clause 5.2; |
(d) | the receipt of all required written consents in a form reasonably acceptable to the Buyer from all relevant third parties unconditionally to transfer the Contracts set out in paragraphs 1(c), 2(a), 2(b), 3(a), 3(b) and 4 of Schedule 10 to the Buyer, or to a Buyer’s Group Company if the Buyer directs, on or prior to 27 February 2015, provided that the form of the consent to assignment for the Xenazine Contract shall be the Xenazine Assignment and Extension Agreement. |
(e) | the Buyer shall have received a certificate of the Seller signed by a duly authorized representative dated as of the Completion Date certifying the matters set forth in clauses 5.3(a) to 5.3(d). |
5.4 | Seller conditions to Completion |
(a) | each Buyer's Warranty shall be true and accurate in all respects as though such warranties had been made on the Completion Date; and |
(b) | the Seller shall have received a certificate of the Buyer signed by a duly authorized representative dated as of the Completion Date certifying the matters set forth in clause 5.4(a). |
5.5 | Mutual conditions to Completion |
(a) | there must not be any law enacted, issued, promulgated, enforced or entered by any Competent Authority and remaining in effect which prohibits or renders illegal the consummation of those transactions; and |
(b) | there must not be pending any Proceeding by any Competent Authority that is or would reasonably be expected to seek to restrain, enjoin, prevent, prohibit or make illegal the consummation of the transactions. |
5.6 | Non-satisfaction |
5.7 | Time and place |
(a) | the Target Date, in the event that (i) the Completion Conditions (other than the Completion Conditions that by their nature are to be satisfied at the Completion) have been satisfied or waived 15 Business Days prior to the Target Date and (ii) fifteen (15) Business Days have elapsed since the date of completion of the French Consultation Process; or |
(b) | in the event that the Completion Conditions (other than the Completion Conditions that by their nature are to be satisfied at the Completion) have not been satisfied or waived 15 Business Days prior to the Target Date, and provided that fifteen (15) Business Days have elapsed since the date of completion of the French Consultation Process, the fifteenth (15) Business Day after the date on which the last Completion Condition (other than any Completion Conditions that by their nature are to be satisfied at Completion) to be satisfied or waived in accordance with this clause 5 is first satisfied or waived (provided that such date shall not be any later than the Long Stop Date); or |
(c) | such other date as may be agreed between the Seller and Buyer in writing. |
5.8 | Completion obligations |
5.9 | Breach of Completion Obligations |
(a) | to defer Completion for a period of up to ten (10) Business Days (so that the provisions of this clause 5 shall apply to Completion as so deferred); |
(b) | to require the parties to proceed to Completion as far as practicable, having regard to the defaults which have occurred; or |
(c) | subject to Completion having first been deferred for a period of at least ten (10) Business Days under clause 5.9(a) and the parties having used reasonable endeavours to effect Completion during that period, to terminate this Agreement by notice in writing to the Seller or Buyer as the case may be. |
6. | BUYER'S WARRANTIES |
6.1 | Buyer's Warranties given at the Offer Date |
6.2 | Buyer's Warranties are separate statements |
7. | SELLER'S WARRANTIES |
7.1 | Seller's Warranties |
7.2 | Seller's Warranties are separate statements |
7.3 | Seller's Warranties qualified by disclosure |
(a) | fairly disclosed in or by: |
(i) | the Disclosure Letter; |
(ii) | the documents that are annexed to the Disclosure Letter or are listed in the index of documents annexed to the Disclosure Letter; |
(iii) | the Data Room Information; or |
(b) | at the Offer Date, within the actual knowledge of Toby Sykes, Evis Hursever, Bryan Morton or Paul Davisson, having reviewed all written reports produced as part of the Buyer's due diligence of the Business, being the legal due diligence report prepared by White & Case LLP and issued on 21 November 2014, the regulatory due diligence report prepared by Precipio Consulting and issued on 10 October 2014, the Caphosol U.S. revenue assessment summary findings prepared by L.E.K. Consulting LLC and issued on 15 August 2014, the financial due diligence report prepared by Deloitte LLP and issued on 2 December 2014 and the HR due diligence report prepared by Volantis Consulting Ltd and issued on 27 November 2014. |
7.4 | Seller's knowledge |
7.5 | No claim against Business employees, directors etc. |
(a) | The Seller agrees not to bring any claim which it may have against an Employee arising out of any information or advice provided (or omitted to be provided) by any such person on which the Seller relied when giving a Seller's Warranty, preparing the Disclosure Letter or otherwise agreeing to the terms of a Transaction Document. |
(b) | The Buyer agrees not to bring any claim which it may have against a Seller's Group Company (other than the Seller) or a present or former officer, adviser, director or employee of a Seller's Group Company or the Business, arising out of any information or advice provided (or omitted to be provided) by any such person on which the Buyer relied when agreeing to the terms of a Transaction Document. |
(c) | Clauses 7.5(a) and (b) do not apply to a claim against a person who is alleged to have acted fraudulently or with wilful misconduct. |
8. | LIMITATIONS ON SELLER'S LIABILITY |
9. | BUSINESS RESPONSIBILITY |
9.1 | Responsibility for Assumed Obligations and Buyer's indemnity |
(a) | perform (subject to clause 10) each Assumed Obligation; |
(b) | assume and thereafter pay, perform and discharge when due all other Assumed Liabilities; |
(c) | pay to the Seller an amount equal to: |
(i) | each Loss which a Seller Indemnified Party incurs: |
(1) | as a result of the Buyer's performance or non-performance of an Assumed Obligation to the extent that the Loss is attributable to the Buyer's act or omission after the Effective Time (except and to the extent that the Seller or a Seller's Group Company has agreed to be responsible for such Assumed Obligation pursuant to the Transitional Services Agreement); or |
(2) | in connection with any other Assumed Liability after the Effective Time, including any Losses arising from (x) the negligent or wilful misconduct of the Buyer or any Buyer's Group Company or any employee thereof, or (y) the breach of any Transaction Document or |
(3) | the provisions contained in the Transitional Services Agreement and Reverse Services Agreement, and not the provisions contained in this clause 9.1(c), shall apply in relation to any Loss suffered by a Seller or Seller's Group Company in connection with the Transitional Services Agreement and Reverse Services Agreement, and shall apply to limit the liability of the Buyer and each Buyer's Group Company accordingly; and |
(4) | this indemnity shall not apply to any Loss which a Seller Indemnified Party incurs as a result of the matters referred to in Schedule 18; |
(ii) | each Loss which a Seller Indemnified Party incurs as a result of investigating, disputing or settling a claim (whether actual or potential), alleging a Loss of the type referred to in clause 9.1(c)(i); and |
(iii) | any reasonably incurred and properly evidenced costs which a Seller Indemnified Party incurs in enforcing its rights under clauses 9.1(c)(i) and/or (ii); and |
(d) | procure performance by the relevant Buyer's Group Company of its obligations under the Reverse Services Agreement. |
9.2 | Responsibility for Retained Obligations and Seller's indemnity |
(a) | perform each Retained Obligation; |
(b) | subject to the Appendix, pay to the Buyer an amount equal to: |
(i) | each Loss which a Buyer Indemnified Party incurs in connection with a Retained Liability; |
(ii) | each Loss which a Buyer Indemnified Party incurs as a result of investigating, disputing or settling a claim (whether actual or potential), alleging a Loss of the type referred to in clause 9.2(b)(i); and |
(iii) | any reasonably incurred and properly evidenced costs which a Buyer Indemnified Party incurs in enforcing its rights under clauses 9.2(b)(i) and/or (ii); and |
(c) | procure performance by the relevant Seller's Group Company of its obligations under the Transitional Services Agreement and the Reverse Services Agreement. |
9.3 | Clauses 9.1(c) and 9.2(b) will not apply in respect of the performance by the Seller or the non-performance by the Buyer of an Assumed Obligation which is due to the operation of clauses 10.2(b) or 10.3. |
9.4 | The provisions of paragraphs 4.1, 5, 6(a), 6(b), 6(c), 6(d), 8, 9 and 11 of Schedule 5 shall apply mutatis mutandis to any claim against the Buyer under clause 9.1 as if all references in those paragraphs to the "Seller" were replaced with the "Buyer". |
9.5 | Any obligations and rights of the Buyer under this clause 9, under clauses 4.8 and 4.9, under clauses 14.2, 14.3, 14.4 and 14.5, under clause 26, under Schedule 18 and under paragraph 3(b) of the Appendix are given by and to the Buyer on behalf of any Nominated Buyer Company to the extent they relate to a portion of the Business acquired by such Nominated Buyer Company. Any obligations and rights of the Seller under this clause 9, under clauses 4.8 and 4.9, under clauses 14.2, 14.3, 14.4 and 14.5, under clause 26, under Schedule 18 and under paragraph 3(b) of the Appendix are given by and to the Seller on behalf of any Relevant Seller's Group Company to the extent they relate to such part of the Business sold by such Relevant Seller's Group Company. |
10. | TRANSFER OF CONTRACTS |
10.1 | Transfer of Contracts that do not require third party consent |
10.2 | Transfer of Contracts that require third party consent and confirmation of Shared Contracts |
(a) | each party must use its reasonable endeavours for a period of twelve (12) months after Completion to take all such steps, as soon as possible, as are necessary to transfer the rights and obligations of the Seller, or the Relevant Seller's Group Company, under the relevant Contract or Shared Contract to the Buyer with effect from the Effective Time; and |
(b) | until the earlier of the date on which such transfer is effected and the date which falls twelve (12) months after the Completion Date, the Seller will and will procure that the Relevant Seller’s Group Company will, after Completion: |
(i) | do everything that the Buyer reasonably requests to provide for the Buyer the benefit of the Seller's, or the Relevant Seller's Group Company, rights under the relevant Contract or Shared Contract; |
(ii) | promptly give to the Buyer any applicable (in the case of a Shared Contract) document or item received by the Seller, or the Relevant Seller's Group Company, in relation to the relevant Contract or Shared Contract; and |
(iii) | at the Buyer's option (so long as it is lawful and not prohibited under the relevant Contract or Shared Contract): |
(1) | do everything and enter into all documents that the Buyer reasonably requests to enable the Buyer to perform the Seller's, or the Relevant Seller's Group Company, obligations under the relevant Contract or Shared Contract as subcontractor or agent for the Seller, or the Relevant Seller's Group Company; or |
(2) | properly perform the Seller's, or the Relevant Seller's Group Company, obligations under the relevant Contract or Shared Contract in which case the Buyer must make sure that the Seller's, or the Relevant Seller's Group Company, reasonable, documented costs of doing so are reimbursed. |
10.3 | Failure to obtain consent to transfer of a Contract or bifurcate a Shared Contract |
10.4 | No transfer of rights or obligations if transfer illegal or in breach of a Contract or Shared Contract |
11. | WRONG POCKETS |
11.1 | Without prejudice to any other rights or remedies of the Buyer under this Agreement, and subject to clause 10 and any specific procedures agreed in relation to the transfer of the Marketing Authorisations, if any Asset or Assumed Liability has not been vested in or transferred to the Buyer or a Nominated Buyer Company by virtue of the transactions carried out under this Agreement and the other Transaction Documents, the Buyer or the Seller may give written notice of this to the other party. If such notice is given the Seller shall, as soon as reasonably practicable at its own cost and so far as it or any Relevant Seller's Group Company is able, transfer or procure the transfer of such Asset or Assumed Liability to the Buyer or, at the Buyer's direction, to another Buyer’s Group Company for no additional consideration, and the Buyer shall, or shall cause another Buyer's Group Company to, accept such Asset or assume such Assumed Liability. |
11.2 | Without prejudice to any other rights or remedies of the parties under this Agreement, and subject to clause 10, if any Retained Asset or Retained Liability is (contrary to the intention of this Agreement) transferred from the Seller to the Buyer or a Nominated Buyer Company in connection with the transactions carried out under this Agreement and the other Transaction Documents, the Seller or the Buyer may give written notice of this to the other party. If such notice is given, the Buyer shall, as soon as reasonably practicable at the Seller's cost and so far as it or the relevant Nominated Buyer Company is able, transfer or procure the transfer of such Retained Asset or Retained Liability to the Seller or, at the Seller’s direction, to another Seller’s Group Company for no consideration, and the Seller shall, or shall cause another Seller's Group Company to, accept such Retained Asset or Retained Liability. |
12. | APPORTIONMENT OF OUTGOINGS AND INCOME |
12.1 | Apportionment of outgoings |
(a) | paid by a Seller's Group Company, the Buyer must pay the Seller (in accordance with clause 12.4) an amount equal to: |
(i) | the proportion of the payment, less |
(ii) | any VAT recoverable by the Seller or the relevant Seller's Group Company, |
(b) | paid by a Buyer's Group Company, the Seller must pay the Buyer (in accordance with clause 12.4) an amount equal to: |
(i) | the proportion of the payment, less |
(ii) | any VAT recoverable by the Buyer or the relevant Buyer's Group Company, |
12.2 | Apportionment of income in respect of VAT |
(a) | a payment in respect of the Business for either: |
(i) | a period which ends on or before the Effective Time (a "Pre-Effective Time Period"); or |
(ii) | a period which starts before the Effective Time and ends after the Effective Time (a "Straddle Period"), |
(b) | all or part of such payment is in respect of VAT which relates to either: |
(i) | a Pre-Effective Time Period; or |
(ii) | such part of a Straddle Period which ends on the Effective Time, |
12.3 | Relevant outgoings |
(a) | payments made in respect of Leased Equipment; |
(b) | fees in respect of any licences or permits (to the extent that they relate to the Business); |
(c) | amounts paid under a Contract or a provision (or provisions) of a Shared Contract that relate to the Business; |
(d) | charges levied on any specific assets; |
(e) | pre-payments for goods and services; |
(f) | wages, salaries and other emoluments (including holiday pay, contributions to pensions, life assurance, permanent health insurance and private health care schemes, but excluding the Bonus Accrual Amount) of the Employees including all income tax deductible at source and national insurance/social security contributions in respect of any such amount described in this clause 12.3(f); |
(g) | Chargebacks, which outgoings shall be apportioned on the basis that the Seller shall bear the entire cost of Chargebacks for products sold by a wholesaler or distributor to an end purchaser customer before the forty-first (41) day after the Completion Date and the Buyer shall bear the entire cost of Chargebacks for products sold by a wholesaler or distributor to an end purchaser customer on or after the forty-first (41) day after the Completion Date. The value of the Chargebacks shall be based on the amount claimed by the relevant wholesaler or distributor as set out in the Specialty Pharmaceutical Services chargebacks report specifically relating to Caphosol US; |
(h) | Customer Rebates, which outgoings shall be apportioned on the basis that the Seller shall be responsible for Customer Rebates up to the Completion Date determined by reference to the "867 data" which shows the volume of Caphosol product shipped to Baylor Health Care and MD Anderson Cancer Centre; |
(i) | Xenazine Rebates, which outgoings shall be apportioned on the basis that the Seller will bear the liability for such proportion of the Xenazine Rebates in respect of the period up to 31 December 2014 as it is obliged to meet under the terms of the Xenazine Agreement in force as at the date of this Agreement and the Buyer will bear the liability for the entire amount of the Xenazine Rebates in respect of the period on and after 1 January 2015, and on the basis that the Seller will refund the Buyer in respect of the proportion of Xenazine Rebates for which the Seller is liable in respect of 2014 within 30 days of receipt of a rebate invoice from the Unions de Recouvrement des Cotisations de Sécurité Sociale et d'Allocations Familiales for Xenazine product sold in 2014; |
(j) | Prompt Payment Discounts, which outgoings shall be apportioned on the basis that the Seller shall bear the cost of the Prompt Payment Discount in respect of the value of the sales of Caphosol in the US market in the period from the date which is 31 days prior to but excluding the Completion Date to the Completion Date (determined by reference to the Specialty Pharmaceutical Services gross sales report) at a rate of two (2) per cent. on such sales; |
(k) | charges and expenses associated with sales and the shipment of products comprised within the Business, including distribution fees, wholesaler fees, logistic fees and all other selling costs; |
(l) | returns, which outgoings shall be apportioned on the basis that: |
(i) | the Seller will bear the cost of refunds to Customers for all returns of products comprised within the Business sold by a Seller Group Company to a Customer prior to the Effective Time ("Seller-Sold Product"), subject to the Buyer undertaking not to change (and procuring that no Buyer's Group Company shall change) the returns policy applied by the Seller's Group in relation to the Business to the extent that it would materially impact the cost of such refunds; and |
(ii) | the Buyer will bear all costs, including refunds to customers, for all returns of products comprised within the Business sold by a Buyer Group Company to a Customer after the Effective Time ("Buyer-Sold Product"). |
(m) | the Seller will reimburse the Buyer in respect of the 2015 Bonus Accrual Amount stated in the Bonus Accrual Amount Statement, assuming the total bonus payments that will be made by the Buyer to the Employees and Non-Automatic Transfer Employees in respect of the period to which the 2015 Bonus Accrual Amount relates (the "Relevant Period") equate to the amount shown in the Bonus Accrual Amount Statement for the 2015 Bonus Accrual Amount, and on the basis that: |
(i) | if the Buyer pays a lower total bonus amount, the Seller will adjust the 2015 Bonus Accrual Amount it reimburses to the Buyer accordingly; |
(ii) | the Buyer shall provide a statement confirming what bonuses will be paid to the Employees and Non-Automatic Transfer Employees in relation to the Relevant Period no less than ten (10) Business Days prior to such payment. The Buyer shall co-operate with the Seller to facilitate the Seller's review of the bonus paid in respect of the Relevant Period and furnish such access to the Buyer and its representatives and to the Buyer's Group Companies' books, records and employees as the Seller may reasonably request for such task; and |
(iii) | the Seller shall, within ten (10) Business Days of receipt of the Buyer's statement provide a statement to the Buyer confirming what 2015 Bonus Accrual Amount it intends to reimburse to the Buyer. Unless either party acting reasonably disputes the other's statement within five (5) Business Days of receipt, such statement shall be deemed final and binding on the parties. The Seller shall pay the amount set out in its statement to the Buyer within five (5) Business Days of it being deemed final and binding. |
12.4 | Payment of apportioned outgoings |
(a) | within fifteen (15) Business Days after the last day of each six (6) month period in the three (3) years from Completion and thereafter at such times and for such periods as the Buyer or the Seller may, acting reasonably, decide (each such date being an "Apportionment True-Up Date" and each such period being an "Apportionment True-Up Period"), the Buyer and the Seller must give the other a notice (the notice prepared by the Buyer being a "Buyer Apportionment Notice" and the notice prepared by the Seller being a "Seller Apportionment Notice") setting out: |
(i) | each payment that is within the scope of clause 12.1 made or received by the Buyer's Group (in the case of a Buyer Apportionment Notice) or the Seller's Group (in the case of a Seller Apportionment Notice) in the relevant Apportionment True-Up Period (excluding, for the avoidance of doubt, any payments in respect of returns, which shall be dealt with in accordance with clause 12.4(d)); |
(ii) | the amount of each payment (if any) that is to be paid to the Seller's Group and/or the Buyer's Group under clause 12.1 in respect of the relevant Apportionment True-Up Period; and |
(iii) | the amount of each payment (if any) that is to be retained by the Buyer and/or the Seller under clause 12.1 in respect of the relevant Apportionment True-Up Period; |
(b) | if, in a Seller Apportionment Notice, the total of the amounts to be paid to the Buyer's Group exceeds the total to be paid to the Seller's Group, the Seller must pay the excess to the Buyer within ten (10) Business Days after the date of the Seller Apportionment Notice; |
(c) | if, in a Buyer Apportionment Notice, the total of the amounts to be paid to the Seller's Group exceeds the total to be paid to the Buyer's Group, the Buyer must pay the excess to the Seller within ten (10) Business Days after the date of the Buyer Apportionment Notice; and |
(d) | in the case of returns of product sold by any Seller's Group Company prior to the Effective Time the Buyer shall provide, within 10 Business Days following each quarter end following the Completion Date, a statement setting out its calculation of the amount payable by the Seller in respect of returns pursuant to clause 12.3(l) together with all supporting information that the Seller may reasonably request to enable it to verify such amount. Unless the Seller disputes the Buyer's calculation within five (5) Business Days of the date of the statement, such statement shall be deemed final and binding on the parties. The Seller shall pay the amount set out in such statement to the Buyer within five (5) Business Days of it being deemed final and binding. |
12.5 | Resolution of disputes under clause 12 |
(a) | the Buyer disputes a Seller Apportionment Notice; or |
(b) | the Seller disputes a Buyer Apportionment Notice or a statement issued by the Buyer in respect of returns in accordance with clause 12.4(d); or |
(c) | either party disputes a statement issued by the other party in respect of bonus amounts in accordance with clause 12.3(m), |
13. | COLLECTION OF ACCOUNTS RECEIVABLE FROM THE SALE OF INVENTORY TO CUSTOMERS |
13.1 | Seller to assist Buyer's collection of Accounts Receivable from the Sale of Inventory to Customers |
13.2 | Additional Seller obligations in respect of Accounts Receivable from the Sale of Inventory to Customers |
(a) | The Seller must not waive, discount or release, and must procure that no other Seller's Group Company waives, discounts or releases, any Accounts Receivable from the Sale of Inventory to Customers or extends the period for payment of an Accounts Receivable from the Sale of Inventory to Customers unless the Seller has obtained the Buyer's written consent. |
(b) | If the Seller, or other Seller's Group Company, receives an amount from a person whose debt is included in an Accounts Receivable from the Sale of Inventory to Customers and who is also a debtor of the Seller's Group, the amount must be applied to satisfy the outstanding debts which were first invoiced to the person. |
14. | EMPLOYEES |
14.1 | The Transfer Regulations |
(a) | the contracts of employment of the Employees will have effect from the Effective Time as if originally made between the Buyer (or a member of the Buyer's Group) and the Employees (except in respect of pension arrangements in so far as they are excluded by reason of the Transfer Regulations) and by virtue of the Transfer Regulations all the Seller's (and/or relevant member of the Seller's Group's) rights, powers, duties and liabilities under or in connection with any such contract of employment with the Employees still in force at the Effective Time shall be transferred to the Buyer (or a relevant member of the Buyer's Group); |
(b) | the employment of any of the Employees who are employed in the Business immediately on or before the Effective Time shall not be terminated for a reason arising from or connected in any way with this Agreement; |
(c) | the parties will (subject to the terms of this Agreement) comply with the requirements of the Transfer Regulations; and |
(d) | for the Employees who: (i) are employed by a Seller's Group Company in France and (ii) benefit from a protective statutory status, their transfer will be subject to the consent from the competent labor governmental authority and therefore: (1) notwithstanding anything to the contrary in this Agreement, Completion can occur without such Employees and such Employees shall transfer when and if the competent labor governmental approval is received; and (2) in the event such Employees' transfer is refused by the competent labor governmental authority, they will remain employed by the Seller's Group Company in France. |
14.2 | Seller's indemnity |
(a) | any breach, act or omission by the Seller (and/or relevant member of the Seller's Group) in relation to the Employees occurring prior to Completion but excluding, for the avoidance of doubt, any Employment Liabilities arising solely as a result of the Employees' accrual of service or which are a consequence of the Buyer's own breach, act or omission; or |
(b) | any failure by the Seller (and/or relevant member of the Seller's Group) to comply with its obligations under the Transfer Regulations except to the extent that any claim is caused by or related to a failure by the Buyer to comply with its obligations under the Transfer Regulations. |
14.3 | Buyer's indemnity |
(a) | any claim by an employee who would have been an Employee but for the termination of his employment before the Effective Time by reason of his resignation in connection with any actual or proposed measure, action or omission (including a proposed change or changes in that employee's working conditions) which the Buyer and/or any member of the Buyer's Group has expressed an intention to take in respect of that employee or any group of employees which includes that employee. The foregoing shall not apply if an Employee resigns or claims constructive dismissal solely due to actual or proposed changes by the Buyer in his/her entitlements under any equity share schemes from which the relevant Employee benefited immediately prior to the Completion Date; |
(b) | any breach, act or omission by the Buyer (or relevant member of the Buyer’s Group) relating to the Employees occurring on or after Completion that is not the consequence of the Seller's own breach, act or omission; |
(c) | any breach on or after the Effective Time by the Buyer (or relevant member of the Buyer’s Group) of any other obligation or any duty (statutory or otherwise) it owes to any of the Employees or to any trade union(s), employee consultation body or works council in respect of the Employees; and |
(d) | any failure by the Buyer and/or member of the Buyer's Group to comply fully with its obligations pursuant to the Transfer Regulations, except to the extent that any claim is caused by or related to a failure by the Seller to comply with its obligations under the Transfer Regulations. |
14.4 | Claims of transfer by Non-Transferring Employees |
(a) | the Buyer (or relevant member of the Buyer's Group) shall notify the Seller in writing within seven days of becoming aware of such claim or allegation ("Buyer's Notification"); |
(b) | within twenty-eight (28) days of the Buyer's Notification, the Seller may make, or may procure a third party to make, an offer of employment to such person on terms that are no less favourable than the terms and conditions of employment of such person in existence immediately prior to Completion (in which case, the Buyer agrees at the Seller's request to release such person immediately from its employment); and |
(c) | if no such offer is made, or is made and not accepted, the Seller agrees to pay to the Buyer the amount of any Loss incurred by the Buyer and/or relevant member of the Buyer's Group in respect of any Employment Liabilities arising from the dismissal of such person (including the cost of providing salary and contractual benefits up to and including the date of such dismissal), excluding however any Employment Liabilities which are related to or arise out of any unlawful discriminatory act by the Buyer (or any member of the Buyer's Group) in relation to any such person or out of any failure by the Buyer (or relevant member of the Buyer's Group) to observe the terms of the relevant Non-Transferring Employee's contract, provided always that (i) any dismissal takes effect or notice to terminate employment is given within forty-two (42) days of the Buyer's Notification and meets the applicable minimum notice entitlements as required by law and (ii) the Buyer shall (and shall procure that each Buyer's Group Company shall) use reasonable endeavours to mitigate such Employment Liabilities. |
14.5 | Claims of non-transfer by Employees |
(a) | the Seller (or the relevant member of the Seller's Group) shall notify the Buyer in writing within seven (7) days of becoming aware of such claim or allegation ("Seller's Notification"); |
(b) | within twenty-eight (28) days of the Seller's Notification, the Buyer may make, or may procure a third party to make, an offer of employment to such person on terms that are no less favourable than those terms and conditions of employment as would have applied if the Employee's employment had automatically transferred to the Buyer pursuant to the Transfer Regulations (in which case, the Seller (or the relevant member of the Seller's Group) agrees at the Buyer's request to release such person immediately from its employment); and |
(c) | if an offer of employment is made by the Buyer under clause 14.5(b) and not accepted, the Buyer shall have no liability to the Seller or any Seller’s Group Company in relation to any Loss suffered by the Seller or a Seller’s Group Company in relation to or in connection with that Employee. |
14.6 | Transfer of Non-Automatic Transfer Employees |
(a) | The Buyer (or relevant member of the Buyer's Group) shall make an offer of employment to each Non-Automatic Transfer Employee for the same base salary as is in effect immediately before the Completion Date, with full credit for such Non-Automatic Transfer Employee's accrued service with Seller, and otherwise on substantially the same terms and conditions of employment in the aggregate as was provided by the appropriate member of the Seller's Group immediately before the Completion Date, including as to location (the one Austrian Non-Automatic Transfer Employee to continue to be based at home and the one UK employee to be based in or around Hemel Hempstead). |
(b) | If an offer of employment is made by the Buyer under clause 14.6(a) and not accepted, notwithstanding any provision of this Agreement, the Buyer shall have no liability to the Seller or any Seller’s Group Company in relation to any Loss suffered by the Seller or a Seller’s Group Company in relation to or in connection with that Non-Automatic Transfer Employee. |
(c) | If an offer of employment is not made by the Buyer which complies with the terms of clause 14.6(a), the Buyer agrees to indemnify and hold harmless the Seller and/or the relevant member of the Seller's Group against any Employment Liabilities arising from the dismissal of such person (including the cost of providing salary and contractual benefits up to and including the date of such dismissal), excluding however any Employment Liabilities which are related to or arise out of any unlawful discriminatory act by the Seller (or member of the Seller's Group) in relation to any such person or out of any failure by the Seller (or relevant member of the Seller's Group) to observe the terms of the relevant Non-Automatic Transfer Employee's contract, provided always that (i) any dismissal takes effect or notice to terminate employment is given within forty-two (42) days of the Completion Date and meets the applicable minimum notice entitlements as required by law and (ii) the Seller shall (and shall procure that each Seller's Group Company shall) use reasonable endeavours to mitigate such Employment Liabilities. The foregoing shall not apply (i.e. the Buyer shall not be required to indemnify or hold harmless the Seller and/or any relevant member of the Seller’s Group) if the sole basis upon which the offer made to the relevant Non-Automatic Transfer Employee did not satisfy the requirements of clause 14.6(a) was because of the proposed changes in his/her entitlements under any equity share schemes from which the relevant Non-Automatic Transfer Employee benefited immediately prior to the Completion Date. |
14.7 | No change to employment terms |
14.8 | Information and consultation |
14.9 | Transferring Employees |
14.10 | Changes to Employees |
(a) | any person who is listed on the Employees List or the Non-Automatic Transfer Employees List ceases (or shall cease before the Effective Time) for any reason to be employed by the Seller or a Seller's Group Company in the United Kingdom, France, Germany, Austria, Belgium, Netherlands, Portugal or Poland, excluding those instances where the dismissal process commenced prior to the Offer Date and the Buyer was made aware of this (it being understood that the Seller shall not, and shall procure that no Seller's Group Company shall, unilaterally dismiss any person who is listed on the Employees List or the Non-Automatic Transfer Employees List, save for (i) misconduct or gross misconduct and (ii) save for those instances where the dismissal was in progress prior to the Offer Date and the Buyer was made aware of this, or (iii) with the Buyer's consent, such consent not to be unreasonably withheld or delayed); |
(b) | any person who is listed on the Employees List or the Non-Automatic Transfer Employees List has given or received notice of termination; and |
(c) | any person is employed or will become employed by the Seller or a Seller's Group Company in the United Kingdom, France, Germany, Austria, Belgium, Netherlands, Portugal or Poland in connection with the Business in accordance with clause 14.9 above, |
14.11 | Time limit |
15. | RETIREMENT BENEFIT PLANS |
16. | ACCESS TO INFORMATION AND EMPLOYEES AND USE OF NAMES |
16.1 | Obligations to pass on information received |
16.2 | Use of names |
16.3 | Restriction on the use of names |
(a) | the name of each Seller's Group Company which incorporates any of the Transferred Names be changed, and the Seller shall provide the Buyer with a copy of the certificate(s) of incorporation on change of name (or any equivalent document) when effected; |
(b) | neither the Seller nor any member of the Seller's Group shall use any mark, logo, name, symbol or design used in the Business; and |
(c) | except as required by applicable law or regulation, all references to the Business (including to the Transferred Names and UPCs) be removed from the websites under any domain names retained by the any member of the Seller’s Group, together with all hypertext links to websites relating to the Business. |
16.4 | Access obligations of the Seller |
(a) | In the period between Signing and Completion, the Seller shall procure that the Buyer and its agents shall be allowed: |
(i) | reasonable access to, and to take copies of (at the Buyer's sole expense), the books, records and documents of or relating in whole or in part to the Business, including to the extent specified in Schedule 16 (Pre-Completion diligence); and |
(ii) | reasonable access to the directors and senior employees of the Seller's Group Companies who are involved with the Business (who shall be instructed to give all such information, assistance and explanations as the Buyer or any person acting on the Buyer's behalf may reasonably request). |
(b) | In the period between Signing and Completion, the Seller shall procure that the Buyer and its agents shall be allowed reasonable access to the employees of the Seller's Group Companies who are listed on the document with index number C attached to the Disclosure Letter and who are partially but not wholly or mainly involved with the Business, to discuss their potential employment in the Seller's Group following Completion. |
(c) | Any access granted pursuant to clause 16.4(a) or 16.4(b) shall only be permitted: |
(i) | within normal working hours and at such times as Anuj Madhok (or such other person notified by the Seller to the Buyer as having responsibility for co-ordinating such access from time to time) may have agreed in advance (such agreement not to be unreasonably withheld or delayed); |
(ii) | in relation to clause 16.4(a), to the extent reasonably required by the Buyer to plan for (a) the integration of the Business into the Buyer's Group, (b) the raising of new indebtedness for the Buyer's Group or the Business or the syndication of existing indebtedness or equity, or (c) any roll out of a management incentive plan to take effect from on or after Completion; |
(iii) | in relation to clause 16.4(b), to the extent reasonably required by the Buyer to plan to potentially employ in the Seller's Group any such employees following Completion; and |
(iv) | provided that access shall not give the Buyer or its agents any right to give instructions or otherwise interfere with the management and conduct of the Business and is otherwise subject to the legal, regulatory and compliance obligations of the Business. |
16.5 | Access obligations of the Buyer |
17. | DATA PROTECTION |
18. | CONFIDENTIALITY |
18.1 | Seller's confidentiality obligations |
(a) | not disclose or use the Buyer's Confidential Information unless it has first obtained the Buyer's permission; and |
(b) | ensure that no Seller's Group Company discloses or uses the Buyer's Confidential Information unless it has first obtained the Buyer's permission. |
18.2 | Buyer's confidentiality obligations |
(a) | not disclose or use the Seller's Confidential Information unless it has first obtained the Seller's permission; and |
(b) | ensure that no Buyer's Group Company discloses or uses the Seller's Confidential Information unless it has first obtained the Seller's permission. |
18.3 | Both parties' confidentiality obligations |
(a) | not disclose information relating to the negotiation, existence or provisions of a Transaction Document unless: |
(i) | it has first obtained the other party's permission; or |
(ii) | permitted under clause 19; and |
(b) | ensure that no member of its Group discloses information relating to the negotiation, existence or provisions of a Transaction Document unless it has first obtained the other party's permission. |
18.4 | Permitted disclosures |
(a) | the disclosure or use is required by applicable law, a court of competent jurisdiction, a competent judicial, governmental, supervisory or regulatory body or a Notified Body; |
(b) | the disclosure or use is required by a rule of a stock exchange or listing authority on which the shares or other securities in a member of the disclosing person's Group are listed or traded; |
(c) | the disclosure is made to the directors, officers or senior employees of a member of the disclosing person's Group for the purpose of ensuring compliance with the terms of a Transaction Document; |
(d) | the disclosure or use is required for the purpose of legal proceedings arising out of a Transaction Document or the disclosure is required to be made to a Tax Authority in connection with the Tax affairs of a member of the disclosing person's Group; |
(e) | the disclosure is made to a professional adviser of the disclosing person, in which case the disclosing person is responsible for ensuring that the professional adviser complies with the terms of clause 18 as if it were a party to this Agreement; |
(f) | the disclosure is made by either the Buyer or a Buyer’s Group Company to: (i) any member of the Buyer’s Group or to any of their respective direct or indirect shareholders, partners, managers, investors or potential investors in any connected fund; and (ii) to any employees of the foregoing; provided, in each case, that the Buyer remains liable for any breach of the confidentiality obligations set out in this Agreement; or |
(g) | the disclosure is made by the Buyer to any bank or financial institution in connection with the financing or refinancing (whether in whole or in part) by the Buyer of the acquisition of the Business; provided, in any such case, the Buyer remains liable for any breach of the confidentiality obligations set out in this Agreement. |
18.5 | Consultation required before a permitted disclosure |
18.6 | Termination of Confidentiality Agreement |
19. | ANNOUNCEMENTS |
19.1 | Permission of other party generally required |
(a) | make or send; or |
(b) | permit another person to make or send on its behalf, |
19.2 | Circumstances in which permission of other party is not required |
(a) | applicable law, a court of competent jurisdiction or a Competent Authority (including the U.S. Securities and Exchange Commission); or |
(b) | a rule of a stock exchange or listing authority on which the shares or other securities of a Seller's Group Company or a Buyer's Group Company are listed or traded. |
20. | COVENANTS |
20.1 | The Seller shall not, and shall procure that none of its subsidiary undertakings from time to time (together, the "Downstream Seller's Group") shall, for a period of three years from the Completion Date, directly or indirectly: |
(a) | subject to clause 20.2, carry on, be engaged in or be economically interested in any business which is in competition with the Business as carried on at Completion (a "Restricted Business"); or |
(b) | induce or seek to induce any Buyer's Group Company employee to become employed whether as employee, consultant or otherwise by any Downstream Seller's Group Company. The placing of an advertisement of a post available to the public generally and the recruitment of a person through an employment agency shall not constitute a breach of this clause 20 provided that no Downstream Seller's Group Company encourages or advises such agency to approach any Buyer's Group Company employee. |
20.2 | The restriction in clause 20.1(a) does not prevent the Downstream Seller's Group from: |
(a) | acquiring an interest in a Restricted Business as part of an acquisition (whether by share acquisition, asset acquisition, merger or any structure which has similar effect) of a business in respect of which no more than 15 per cent. of the acquired business' total net revenue (as shown in the most recent relevant audited annual accounts) is generated as a result of it owning any Restricted Business; |
(b) | holding shares in a listed company when no Downstream Seller's Group Company exercises, directly or indirectly, any management function in the company concerned or any material influence in that company, which shall be taken to be the case if the shares do not confer more than five per cent of the votes which would normally be cast at a general meeting of the company; |
(c) | holding any securities or having any interest in any person (for the avoidance of doubt not being a member of the Downstream Seller's Group) where the main activity of such person is to make, select, hold or management investments in start-up or other businesses or having any interest in any investment made, selected, held or managed by such person, provided that: |
(i) | no member of the Downstream Seller's Group is able to control or direct such person with respect to the selection or making of such investments; and |
(ii) | no member of the Downstream Seller's Group is able to control or direct the management of any investment so made; or |
(d) | carrying out its obligations in connection with the Transitional Services Agreement. |
20.3 | Without prejudice and subject to any applicable terms of the Transitional Services Agreement, the Seller shall, and shall procure that any relevant Seller's Group Companies shall, use its best endeavours as of the Effective Date to assist the Buyer and the Buyer's Group Companies to obtain: |
(a) | applicable authorisations which are material to the research, development, testing, manufacture, handling, labelling, packaging, storage, supply, promotion, distribution, marketing (including the Marketing Authorisations), commercialisation, importation, export, safety and sale of the Topaz Portfolio of Products and otherwise to enable the Business to be conducted as presently conducted; and |
(b) | applicable authorisations in France which are material to the ATU Business, which are currently held by the Seller or any Seller's Group Company. |
21. | ASSIGNMENT |
21.1 | The Buyer is not permitted to assign, charge or otherwise dispose of any of its rights or benefits under this Agreement or grant or create any third party interest in any of its rights under this agreement (including holding an interest on trust for another) without the prior permission of the Seller, except: |
(a) | the Buyer may assign to any Buyer's Group Company and/or to any third party which is a successor in title to the Buyer in respect of all or a material part of the Business or Assets; and |
(b) | the Buyer or any Buyer’s Group Company (as applicable) may charge and/or assign the benefit of this Agreement to any bank or financial institution or other person (a "Funding Party") by way of security for the purposes of or in connection with the financing or refinancing (whether in whole or in part) of the acquisition of the Business and the Assets. Any Funding Party may at any time assign its rights under this Agreement to any person who has purchased, directly or indirectly, all or a material part of the Business or Assets or substantially all the assets of the Buyer's Group pursuant to the enforcement, by such Funding Party, of its security. |
21.2 | Notwithstanding clause 2.4, clause 9.5 or clause 21.1, neither the Seller nor any Relevant Seller's Group Company shall incur any greater liability (including, but not limited to, liability |
22. | NOTICES AND CLAIMS FOR PAYMENT |
22.1 | Method of giving a notice or other communication |
(a) | in writing; |
(b) | in English; |
(c) | signed by or on behalf of the person giving it; and |
(d) | delivered by hand or sent by recorded delivery post or by fax or by email to the relevant party to the contact, address and fax number set out in clause 22.3 (or if otherwise notified by the relevant person under clause 22.7 to such other contact, address or fax number as has been so notified). |
22.2 | Notice not properly given unless copy also given |
22.3 | Addresses |
(a) | in the case of the Seller as follows: |
Address: | Fourth Floor, Connaught House, One Burlington Road, Dublin 4, Ireland |
(b) | in the case of the Buyer, as follows: |
22.4 | Time that notice or communication is deemed given |
(a) | if delivered by hand, at the time of delivery, except as provided in clause 22.5; |
(b) | if sent by recorded delivery post, at 9.00 am on the second Business Day after the day of posting; |
(c) | if sent by fax, at the time of its transmission, except as provided in clause 22.5; and |
(d) | if sent by email, at the time when it is received on the recipient's computer, except as provided in clause 22.5. |
22.5 | Effect of delivery by hand or fax or email after 6.00 pm or on a non-Business Day |
(a) | If deemed delivery under clause 22.4 of a notice or other communication delivered by hand or sent by fax or email occurs before 9.00 am on a Business Day, the notice or other communication is deemed delivered at 9.00 am on that day. |
(b) | If deemed delivery under clause 22.4 of a notice or other communication delivered by hand or sent by fax or email occurs after 6.00 pm on a Business Day or on a day which is not a Business Day, the notice or communication is deemed to have been given at 9.00 am on the next Business Day. |
22.6 | Relevant time of day |
22.7 | Notification of change in notice details |
22.8 | Claims for payment |
23. | PAYMENTS |
24. | FURTHER ASSURANCE |
25. | COSTS |
26. | GROSS UP |
26.1 | All sums payable by either party under this Agreement shall be paid free and clear of all deductions or withholdings of any kind, save only as may be required by law. |
26.2 | If any deduction or withholding is required as stated in clause 26.1 (save in respect of interest under clause 27 of this Agreement), the payer shall pay to the payee such sum as will after such deduction or withholding has been made leave the payee with the same amount as it would otherwise have received in the absence of any such requirement to make a deduction or withholding. |
26.3 | To the extent that any deduction or withholding in respect of which an additional amount has been paid under clause 26.2 results in the payee obtaining a Relief, the payee must pay to the payer, within ten (10) Business Days of the use or set off of the Relief, an amount equal to the lesser of the Tax saved as a result of such use or set off and the additional sum paid under clause 26.2, provided that the payee will not be obliged to pay to the payer an amount in excess of the amount which will leave it (after that payment) in the same after Tax position as it would have been in had there been no payment under this Agreement in respect of which such deduction or withholding arose. |
26.4 | If any sum payable by either party under this Agreement other than the Purchase Price paid (the "original payment") is subject to Tax in the hands of the payee, the payer shall be obliged to pay to the payee such additional amount (the "additional payment") as will ensure that, after the payment of the Tax so charged on the original payment and any Tax chargeable on the additional payment, there shall remain a net sum equal to the amount of the original payment. Such additional payment shall be paid three Business Days after the payee has served notice that Tax on the original payment has become due and payable, or would have become due and payable but for the availability of any Relief. |
27. | INTEREST ON LATE PAYMENT |
28. | VARIATION AND AMENDMENTS |
29. | WAIVER |
30. | COUNTERPARTS |
31. | EFFECT OF COMPLETION |
32. | ENTIRE AGREEMENT AND LOCAL AGREEMENTS |
32.1 | Entire agreement |
32.2 | No reliance on a statement outside this Agreement |
32.3 | Buyer's only remedy is damages for breach of contract under this Agreement |
(a) | The Buyer has no claim or remedy in respect of a warranty, statement, misrepresentation (whether negligent or innocent) or undertaking made to it by or on behalf of the Seller in connection with or relating to a Transaction which is not expressly included in a Transaction Document. |
(b) | The only claim or remedy that is available to the Buyer in respect of a warranty, statement, misrepresentation (whether negligent or innocent) or undertaking made to it by or on behalf of the Seller is a claim for damages for breach of this Agreement and not termination, rescission, damages in tort, damages under statute or any other remedy. |
32.4 | Local agreements |
32.5 | Clause does not apply in the event of fraud |
33. | INVALIDITY |
34. | THIRD PARTY RIGHTS |
34.1 | Exclusion of Contracts (Rights of Third Parties) Act 1999, subject to exceptions |
34.2 | Exceptions to exclusion of Contracts (Rights of Third Parties) Act 1999 |
(a) | a Seller's Group Company, other than the Seller, may in its own right enforce the obligations of the Buyer contained in clauses 7.5(b), 18.2 and 19; |
(b) | a present or former officer, adviser, director or employee of a Seller's Group Company or the Business may in its own right enforce the Buyer's undertaking contained in clause 7.5(b); |
(c) | a Relevant Seller's Group Company may in its own right enforce any rights given by and to the Seller on behalf of such Relevant Seller's Group Company in accordance with clause 9.5; |
(d) | a Nominated Buyer Company may in its own right enforce any rights given by and to the Buyer on behalf of such Nominated Buyer Company in accordance with clause 9.5; |
(e) | an Employee may in his or her own right enforce the obligations of the Seller contained in clause 7.5(a). |
34.3 | Termination and variation without Third Party permission |
34.4 | Seller's permission required for enforcement |
34.5 | Assignment of rights under Contracts (Rights of Third Parties) Act 1999 |
35. | GOVERNING LAW AND ARBITRATION |
35.1 | Governing law |
35.2 | Arbitration |
35.3 | Multiple disputes |
(a) | If multiple disputes arise out of or in connection with this Agreement and one or more of the Transaction Documents to which the Seller and/or any Seller's Group Company on the one hand and the Buyer and/or any Buyer's Group Company on the other hand are party (each a "Related Agreement"), then any or all such disputes may be determined in a single arbitration. |
(b) | At any time prior to the commencement of the oral phase of the first of any arbitrations commenced under any of the Related Agreements, the tribunal in such arbitration (the "First Tribunal") shall order consolidation of any existing or pending arbitrations commenced under any of the Related Agreements where: |
(i) | the existing or pending arbitrations relate to substantially similar questions of law or of fact; |
(ii) | none of the parties would be unduly prejudiced; and |
(iii) | consolidation under these circumstances would not result in undue delay for any existing or pending arbitration. |
(c) | The tribunal in such a consolidated arbitration shall be selected as follows: |
(i) | the parties to the consolidated arbitration shall agree on the composition of the tribunal; or |
(ii) | failing such agreement within thirty (30) days of consolidation being ordered by the First Tribunal, the LCIA Court will appoint all members of the tribunal within thirty (30) days of a written request by any of the parties to the consolidated arbitration. |
(d) | The parties agree that upon consolidation, they will promptly dismiss any arbitration brought under any Related Agreement, the subject of which has been consolidated into another arbitration in accordance with this clause. |
35.4 | Injunctive relief |
35.5 | Service of process |
35.6 | Appointment of agent for service |
(a) | The Seller must at all times maintain an agent for service of process in England and Wales. |
(b) | The Seller appoints EUSA Pharma (Europe) Limited of Wing B, Building 5700, Spires House, John Smith Drive, Oxford Business Park South, Oxford, OX4 2RW as its agent to accept service of any Process Document in England. |
(c) | Any Process Document will be sufficiently served on the Seller if delivered to its agent at its address for the time being. |
(d) | A party must not revoke the authority of its agent. If the agent ceases to be able to act as such or to have an address within the jurisdiction of the English courts, the party concerned must promptly appoint another agent (with an address for service within the jurisdiction of the English courts). |
(e) | Each party must notify the other within fourteen (14) days of any change in the identity or address of its agent for service of process. |
(f) | This clause 35.6 does not prevent a Process Document being served in another manner permitted by law. |
Signed by __________________________ for and on behalf of Jazz Pharmaceuticals PLC | ) ) ) | /s/ Patricia Carr | |
Signed by __________________________ for and on behalf of Essex Bidco Limited | ) ) ) | /s/ Emma Johnson | |
Historical - Pre-Disposition | Pro Forma Adjustments for the Disposition | Notes | Pro Forma As Adjusted for the Disposition | ||||||||||
ASSETS | |||||||||||||
Current assets: | |||||||||||||
Cash and cash equivalents | $ | 684,042 | $ | 32,833 | (A) | $ | 716,875 | ||||||
Accounts receivable, net | 186,371 | — | 186,371 | ||||||||||
Inventories | 30,037 | — | 30,037 | ||||||||||
Prepaid expenses | 12,800 | — | 12,800 | ||||||||||
Deferred tax assets, net | 48,440 | — | 48,440 | ||||||||||
Other current assets | 21,322 | — | 21,322 | ||||||||||
Assets held for sale | 32,833 | (32,833 | ) | (B) | — | ||||||||
Total current assets | 1,015,845 | — | 1,015,845 | ||||||||||
Property and equipment, net | 58,363 | — | 58,363 | ||||||||||
Intangible assets, net | 1,437,435 | — | 1,437,435 | ||||||||||
Goodwill | 702,713 | — | 702,713 | ||||||||||
Deferred tax assets, net, non-current | 75,494 | — | 75,494 | ||||||||||
Deferred financing costs | 33,174 | — | 33,174 | ||||||||||
Other non-current assets | 15,931 | — | 15,931 | ||||||||||
Total assets | $ | 3,338,955 | $ | — | $ | 3,338,955 | |||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY | |||||||||||||
Current liabilities: | |||||||||||||
Accounts payable | $ | 25,126 | $ | — | $ | 25,126 | |||||||
Accrued liabilities | 164,091 | — | 164,091 | ||||||||||
Current portion of long-term debt | 9,428 | — | 9,428 | ||||||||||
Income taxes payable | 7,588 | 689 | (B) | 8,277 | |||||||||
Deferred tax liability, net | 9,430 | — | 9,430 | ||||||||||
Deferred revenue | 1,138 | — | 1,138 | ||||||||||
Total current liabilities | 216,801 | 689 | 217,490 | ||||||||||
Deferred revenue, non-current | 4,499 | — | 4,499 | ||||||||||
Long-term debt, less current portion | 1,333,000 | — | 1,333,000 | ||||||||||
Deferred tax liability, net, non-current | 375,054 | — | 375,054 | ||||||||||
Other non-current liabilities | 38,393 | — | 38,393 | ||||||||||
Shareholders’ equity: | |||||||||||||
Ordinary shares | 6 | — | 6 | ||||||||||
Non-voting euro deferred shares | 55 | — | 55 | ||||||||||
Capital redemption reserve | 471 | — | 471 | ||||||||||
Additional paid-in capital | 1,458,005 | — | 1,458,005 | ||||||||||
Accumulated other comprehensive loss | (122,097 | ) | — | (122,097 | ) | ||||||||
Retained earnings | 34,704 | (689 | ) | (B) | 34,015 | ||||||||
Total Jazz Pharmaceuticals plc shareholders' equity | 1,371,144 | (689 | ) | 1,370,455 | |||||||||
Noncontrolling interests | 64 | — | 64 | ||||||||||
Total shareholders’ equity | 1,371,208 | (689 | ) | 1,370,519 | |||||||||
Total liabilities and shareholders’ equity | $ | 3,338,955 | $ | — | $ | 3,338,955 |
Historical - Pre-Disposition | Pro Forma Adjustments for the Disposition | Notes | Pro Forma As Adjusted for the Disposition | ||||||||||
Revenues: | |||||||||||||
Product sales, net | $ | 1,162,716 | $ | (26,984 | ) | (C) | $ | 1,135,732 | |||||
Royalties and contract revenues | 10,159 | (240 | ) | (C) | 9,919 | ||||||||
Total revenues | 1,172,875 | (27,224 | ) | 1,145,651 | |||||||||
Operating expenses: | |||||||||||||
Cost of product sales (excluding amortization of acquired developed technologies and intangible asset impairment) | 117,418 | (10,679 | ) | (C) | 106,739 | ||||||||
Selling, general and administrative | 406,114 | (10,274 | ) | (C) | 395,840 | ||||||||
Research and development | 85,181 | — | 85,181 | ||||||||||
Acquired in-process research and development | 202,626 | — | 202,626 | ||||||||||
Intangible asset amortization | 126,584 | (8,704 | ) | (C) | 117,880 | ||||||||
Impairment charges | 39,365 | (39,365 | ) | (C) | — | ||||||||
Total operating expenses | 977,288 | (69,022 | ) | 908,266 | |||||||||
Income from operations | 195,587 | 41,798 | 237,385 | ||||||||||
Interest expense, net | (52,713 | ) | — | (52,713 | ) | ||||||||
Foreign currency gain | 8,683 | — | 8,683 | ||||||||||
Income before income tax provision | 151,557 | 41,798 | 193,355 | ||||||||||
Income tax provision | 94,231 | 12,828 | (C) | 107,059 | |||||||||
Net income | 57,326 | 28,970 | 86,296 | ||||||||||
Net loss attributable to noncontrolling interests, net of tax | (1,061 | ) | — | (1,061 | ) | ||||||||
Net income attributable to Jazz Pharmaceuticals plc | $ | 58,387 | $ | 28,970 | $ | 87,357 | |||||||
Net income per ordinary share attributable to Jazz Pharmaceuticals plc: | |||||||||||||
Basic | $ | 0.98 | $ | 1.46 | |||||||||
Diluted | $ | 0.93 | $ | 1.40 | |||||||||
Weighted-average ordinary shares used in calculating net income per ordinary share attributable to Jazz Pharmaceuticals plc: | |||||||||||||
Basic | 59,746 | 59,746 | |||||||||||
Diluted | 62,614 | 62,614 |
(A) | To reflect the cash received from the Disposition, net of estimated selling costs. |
(B) | To remove assets related to the Disposition, which were classified as assets held for sale as of December 31, 2014, from the balance sheet and reflect taxes payable on the Disposition. |
(C) | To reflect the impact on operating results as if the Disposition had occurred on January 1, 2014. The adjustments include an impairment charge of $39.4 million that was incurred in 2014 to write the carrying value of assets associated with the Disposed Business down to fair value less costs to sell. The pro forma tax benefit adjustment primarily relates to the release of a deferred tax liability, recognized when the assets were initially acquired and recognized at fair value, on impairment. |